Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is …
Biotechnology
US, Palo Alto [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Eiger BioPharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
Eiger BioPharmaceuticals, Inc. has no acquisition track records yet.